PFEPfizerFinished
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause
Breast Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 121 (final count)
- Started
- Jul 11, 2024
- Main results expected
- Jul 10, 2025
- Fully finished
- Jul 10, 2025
- Results posted
- Jul 15, 2026
What counts as success
The trial's main goal(s), called the “primary outcome.”
Percentage of Participants With Complete Cell Cycle Arrest (CCCA) at Day 14
Measured over: Day 14
Changes Tremor has spotted
Paperwork edit (contacts, locations, wording). Usually harmless.
Spotted
Show details (technical version)
Score inputs
- none
Raw record changes
- 2026-11-06 15:29 UTC · paperwork · other
old: null
new: null
details: {"sections":["referencesModule"]}
Trial ID NCT06465368 · record last updated 2026-07-15 · checked 2026-11-09 15:36 UTC